English
Insider transactions
EDGARADAGIO MEDICAL HOLDINGS, INC.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-19.
- Open-market purchases (code P)
- 2 transactions, 222,315 shares
- Sum of shares × price per share: 243,946.35
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–11 of 11
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-16 Filed 2026-08-12 | Salmon Sean Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 30,000 | 0 | — | 30,000 | Direct (D) | No | F1
| Open filing 0001792380-26-000002 Read from the filing’s XML Dispute this row |
| 2026-06-16 Filed 2026-08-12 | Cox James L Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 30,000 | 0 | — | 30,000 | Direct (D) | No | F1
| Open filing 0001665442-26-000002 Read from the filing’s XML Dispute this row |
| 2026-06-16 Filed 2026-08-12 | GARDINER SANDRA A. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 30,000 | 0 | — | 30,000 | Direct (D) | No | F1
| Open filing 0001218574-26-000002 Read from the filing’s XML Dispute this row |
| 2026-06-16 Filed 2026-08-12 | MISHAN ORLY Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 100,000 | 0 | — | 100,000 | Direct (D) | No | F1
| Open filing 0001830911-26-000002 Read from the filing’s XML Dispute this row |
| 2026-06-16 Filed 2026-08-12 | Mirsaeedi-Farahani Keyvan Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 30,000 | 0 | — | 30,000 | Direct (D) | No | F1
| Open filing 0002031256-26-000002 Read from the filing’s XML Dispute this row |
| 2026-06-16 Filed 2026-08-12 | Moran Timothy P. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 30,000 | 0 | — | 30,000 | Direct (D) | No | F1
| Open filing 0001753958-26-000002 Read from the filing’s XML Dispute this row |
| 2026-03-06 Filed 2026-03-09 | Kaster Deborah Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 490,500 | 0 | — | 490,500 | Direct (D) | No | F1
| Open filing 0002089223-26-000002 Read from the filing’s XML Dispute this row |
| 2026-03-06 Filed 2026-03-09 | Usen Todd Director · Officer: Chief Executive Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 800,000 | 0 | — | 800,000 | Direct (D) | No | F1
| Open filing 0001964615-26-000003 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-18 | Kaster Deborah Officer: Chief Financial Officer | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 15,000 | 1.1982 | 17,973Derived: shares × price per share. Exact value 17973.0000. | 15,000 | Direct (D) | No | F1, F2
| Open filing 0002089223-25-000002 Read from the filing’s XML Dispute this row |
| 2025-12-12 Filed 2025-12-15 | Usen Todd Director · Officer: Chief Executive Officer | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 207,315 | 1.09 | 225,973.35Derived: shares × price per share. Exact value 225973.35. | 207,315 | Direct (D) | No | F1, F2
| Open filing 0001964615-25-000003 Read from the filing’s XML Dispute this row |
| 2025-12-11 Filed 2025-12-11 | Salmon Sean Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 90,000 | 0 | — | 90,000 | Direct (D) | No | F1
| Open filing 0001104659-25-120419 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-18. Prior quarter ending 2026-06-30: 9,170 filings read.
Showing 1–24 of 24
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 9,876,586 SH | 1,511,117 dollars | Unchanged Prior quarter: 9,876,586 | Open filing 0001012975-26-001063 Filed 2026-11-16 Dispute this row |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,258,501 SH | 192,551 dollars | Unchanged Prior quarter: 1,258,501 | Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row |
| Alyeska Investment Group, L.P. | 1,159,615 SH | 177,421 dollars | Unchanged Prior quarter: 1,159,615 | Open filing 0001172661-26-005329 Filed 2026-11-16 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 661,191 SH | 101,162 dollars | Higher by 582,076 Prior quarter: 79,115 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| SILVERARC CAPITAL MANAGEMENT, LLC | 170,460 SH | 26,080 dollars | Lower by 53,900 Prior quarter: 224,360 | Open filing 0001420506-26-002577 Filed 2026-11-12 Dispute this row |
| JANE STREET GROUP, LLC Partly reported under another manager | 118,729 SH | 18,166 dollars | Not in the prior quarter’s filings read | Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 108,954 SH | 16,670 dollars | Unchanged Prior quarter: 108,954 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| Affinity Asset Advisors, LLC | 80,000 SH | 12,240 dollars | Unchanged Prior quarter: 80,000 | Open filing 0001011438-26-000687 Filed 2026-11-13 Dispute this row |
| CITADEL ADVISORS LLC Partly reported under another manager | 76,212 SH | 11,660 dollars | Higher by 60,057 Prior quarter: 16,155 | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| HRT FINANCIAL LP | 53,814 SH | 8 dollars | Higher by 40,109 Prior quarter: 13,705 | Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 53,782 SH | 8,229 dollars | Unchanged Prior quarter: 53,782 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| XTX Topco Ltd Partly reported under another manager | 45,657 SH | 6,986 dollars | Higher by 27,504 Prior quarter: 18,153 | Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager | 39,205 SH | 5,998 dollars | Not in the prior quarter’s filings read | Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 30,875 SH | 4,724 dollars | Unchanged Prior quarter: 30,875 | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| TORONTO DOMINION BANK Partly reported under another manager | 25,000 SH | 3,825 dollars | Unchanged Prior quarter: 25,000 | Open filing 0002052595-26-000123 Filed 2026-11-16 Dispute this row |
| Point72 Asset Management, L.P. | 20,143 SH | 3,082 dollars | Not in the prior quarter’s filings read | Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row |
| Opaleye Management Inc. | 18,444 SH | 2,822 dollars | Unchanged Prior quarter: 18,444 | Open filing 0001420506-26-002880 Filed 2026-11-16 Dispute this row |
| BANK OF AMERICA CORP /DE/ Partly reported under another manager | 14,215 SH | 2,175 dollars | Higher by 2,684 Prior quarter: 11,531 | Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row |
| Vanguard Personalized Indexing Management, LLC | 11,960 SH | 1,830 dollars | Not in the prior quarter’s filings read | Open filing 0001104659-26-127786 Filed 2026-11-16 Dispute this row |
| Nuveen, LLC Partly reported under another manager | 9,347 SH | 1,346 dollars | Not in the prior quarter’s filings read | Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row |
| Tower Research Capital LLC (TRC) Partly reported under another manager | 4,267 SH | 653 dollars | Lower by 2,187 Prior quarter: 6,454 | Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row |
| Robinhood Markets, Inc. | 469 SH | 71 dollars | Not in the prior quarter’s filings read | Open filing 0000950157-26-001278 Filed 2026-11-18 Dispute this row |
| Strategic Financial Concepts, LLC | 19 SH | 3 dollars | Not in the prior quarter’s filings read | Open filing 0001754960-26-001004 Filed 2026-11-16 Dispute this row |
| BARCLAYS PLC Partly reported under another manager | 1 SH | 0 dollars | Lower by 22 Prior quarter: 23 | Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- ADAR1 Capital Management, LLC 1,205,447 SH
- Sio Capital Management, LLC 698,989 SH
- Shaolin Capital Management LLC 171,170 SH
- CITIGROUP INC 13,255 SH
- UBS Group AG 2,268 SH
- Crewe Advisors LLC 500 SH
- MORGAN STANLEY 137 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Perceptive Advisors LLC Common Stock, par value $0.0001 per share | 44.4 | 523,356 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001193125-26-463801 Dispute this row |
| Joseph Edelman Common Stock, par value $0.0001 per share | 44.4 | 523,356 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001193125-26-463801 Dispute this row |
| Perceptive Life Sciences Master Fund, Ltd. Common Stock, par value $0.0001 per share | 43.9 | 516,660 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001193125-26-463801 Dispute this row |
| C2 Life Sciences LLC Common Stock, par value $0.0001 per share | 0.7 | 6,696 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 4 | Open filing 0001193125-26-463801 Dispute this row |
| ADAR1 Capital Management, LLC Common Stock, par value $0.0001 per share | 5.4 | 1,205,447.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-097340 Dispute this row |
| Daniel Schneeberger Common Stock, par value $0.0001 per share | 5.4 | 1,205,447.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-097340 Dispute this row |
| Sio Capital Management, LLC Common Stock, par value, $0.0001 per share | 3.15 | 698,989.00 | 06/30/2026 Filed 2026-07-28 | SCHEDULE 13G/AAmendment 1 | Open filing 0001214659-26-009111 Dispute this row |
| Perceptive Advisors LLC Common Stock, par value $0.0001 per share | 55.4 | 15,321,655 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-26-226569 Dispute this row |
| Joseph Edelman Common Stock, par value $0.0001 per share | 55.4 | 15,321,655 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-26-226569 Dispute this row |
| Perceptive Life Sciences Master Fund, Ltd. Common Stock, par value $0.0001 per share | 54.7 | 15,120,753 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-26-226569 Dispute this row |
| C2 Life Sciences LLC Common Stock, par value $0.0001 per share | 0.9 | 200,902 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-26-226569 Dispute this row |
| Adage Capital Management, L.P. Common Stock, par value $0.0001 per share | 5.67 | 1,258,501.00 | 03/31/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 2 | Open filing 0000919574-26-002906 Dispute this row |
| Robert Atchinson Common Stock, par value $0.0001 per share | 5.67 | 1,258,501.00 | 03/31/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 2 | Open filing 0000919574-26-002906 Dispute this row |
| Phillip Gross Common Stock, par value $0.0001 per share | 5.67 | 1,258,501.00 | 03/31/2026 Filed 2026-05-13 | SCHEDULE 13G/AAmendment 2 | Open filing 0000919574-26-002906 Dispute this row |
| ADAR1 Capital Management, LLC Common Stock, par value $0.0001 per share | 5.7 | 1,205,447.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G | Open filing 0001104659-26-016658 Dispute this row |
| Daniel Schneeberger Common Stock, par value $0.0001 per share | 5.7 | 1,205,447.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G | Open filing 0001104659-26-016658 Dispute this row |
| Alyeska Investment Group, L.P. Common Stock, par value $0.0001per share | 9.9 | 2,096,784.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G | Open filing 0001172661-26-001152 Dispute this row |
| Alyeska Fund GP, LLC Common Stock, par value $0.0001per share | 9.9 | 2,096,784.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G | Open filing 0001172661-26-001152 Dispute this row |
| Anand Parekh Common Stock, par value $0.0001per share | 9.9 | 2,096,784.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G | Open filing 0001172661-26-001152 Dispute this row |
| Perceptive Advisors LLC Common Stock, par value $0.0001 per share | 57.5 | 15,321,655 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-054521 Dispute this row |
| Joseph Edelman Common Stock, par value $0.0001 per share | 57.5 | 15,321,655 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-054521 Dispute this row |
| Perceptive Life Sciences Master Fund, Ltd. Common Stock, par value $0.0001 per share | 56.8 | 15,120,753 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-054521 Dispute this row |
| C2 Life Sciences LLC Common Stock, par value $0.0001 per share | 0.8 | 200,902 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-054521 Dispute this row |
| Sio Capital Management, LLC Common Stock, par value, $0.0001 per share | 6.08 | 1,288,461.00 | 12/31/2025 Filed 2026-02-11 | SCHEDULE 13G | Open filing 0001214659-26-001504 Dispute this row |
| Adage Capital Management, L.P. Common Stock, par value $0.0001per share | 6.88 | 1,058,501.00 | 09/30/2025 Filed 2025-11-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0000902664-25-004885 Dispute this row |
| Robert Atchinson Common Stock, par value $0.0001per share | 6.88 | 1,058,501.00 | 09/30/2025 Filed 2025-11-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0000902664-25-004885 Dispute this row |
| Phillip Gross Common Stock, par value $0.0001per share | 6.88 | 1,058,501.00 | 09/30/2025 Filed 2025-11-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0000902664-25-004885 Dispute this row |
| RA Capital Management, L.P. Common Stock, par value $0.0001 per share | 7.2 | 1,200,000.00 | 06/30/2025 Filed 2025-08-26 | SCHEDULE 13G/AAmendment 4 | Open filing 0001415889-25-023033 Dispute this row |
| Peter Kolchinsky Common Stock, par value $0.0001 per share | 7.2 | 1,200,000.00 | 06/30/2025 Filed 2025-08-26 | SCHEDULE 13G/AAmendment 4 | Open filing 0001415889-25-023033 Dispute this row |
| Rajeev Shah Common Stock, par value $0.0001 per share | 7.2 | 1,200,000.00 | 06/30/2025 Filed 2025-08-26 | SCHEDULE 13G/AAmendment 4 | Open filing 0001415889-25-023033 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, par value $0.0001 per share | 6.9 | 1,140,000.00 | 06/30/2025 Filed 2025-08-26 | SCHEDULE 13G/AAmendment 4 | Open filing 0001415889-25-023033 Dispute this row |
| RA Capital Management, L.P. Common Stock, par value $0.0001 per share | 0.0 | 0.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001415889-25-021993 Dispute this row |
| Peter Kolchinsky Common Stock, par value $0.0001 per share | 0.0 | 0.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001415889-25-021993 Dispute this row |
| Rajeev Shah Common Stock, par value $0.0001 per share | 0.0 | 0.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001415889-25-021993 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, par value $0.0001 per share | 0.0 | 0.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001415889-25-021993 Dispute this row |
| Adage Capital Management, L.P. Common Stock, par value $0.0001 per share | 5.34 | 821,261.00 | 06/30/2025 Filed 2025-08-12 | SCHEDULE 13G | Open filing 0000902664-25-003511 Dispute this row |
| Robert Atchinson Common Stock, par value $0.0001 per share | 5.34 | 821,261.00 | 06/30/2025 Filed 2025-08-12 | SCHEDULE 13G | Open filing 0000902664-25-003511 Dispute this row |
| Phillip Gross Common Stock, par value $0.0001 per share | 5.34 | 821,261.00 | 06/30/2025 Filed 2025-08-12 | SCHEDULE 13G | Open filing 0000902664-25-003511 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,538,477 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 17,857 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 166,957 |
| 2021 | 249,835 |
| 2022 | 229,495 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 262,403 |
Filings made before the SEC required XML are listed, not extracted.